skip to main
|
skip to sidebar
Blog Archives: Nov 2004 - present
Special items: Ovarian Cancer and Us blog best viewed in Firefox
"When Ignace Vergote opted to specialise in gynaecological oncology, his country wasn't ready, and he's been waiting for the world to catch up with him ever since....."
~~~~~~~
"....The problem is well illustrated by Vergote’s own experience. When asked
about the research he is most proud of, Vergote points to an academic
study published a year ago in the New England Journal of Medicine,
which was independently funded and has already had a global impact.
Sponsored by the EORTC, it analysed outcomes in advanced ovarian cancer
surgery according to whether the debulking surgery was timed before or
during chemotherapy.
“I was very proud of this. But it took us ten years. We had to randomise
720 patients and, because it wasn’t sponsored, people had to be very
committed and give their time for free – talking to patients, gaining
informed consent, all these things without financial support. It’s very
difficult. So I am proud of that.”...
~~~~~
" He believes that more accurate tumour markers than CA125 need to be found – and his department is working on this problem.
“In 20 years, I think that maybe we will have a marker that will be more
specific and good enough for screening. But I think it’s still too
early to conclude that we have found it.” "
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.